Effect of orthotopic liver transplantation on bone mineral content and serum vitamin D metabolites in infants and children with chronic cholestasis

Almost all infants and children with chronic cholestasis have osteopenia. We evaluated the effect of orthotopic liver transplantation on bone mineral content and serum 25(OH)‐vitamin D–[25(OH)D]–of nine infants and children (five girls; age, 6 to 21 mo at the time of orthotopic liver transplantation) with end‐stage liver disease resulting from chronic cholestasis. We hypothesized that after orthotopic liver transplantation, decreased bone mineral content will recover and the serum 25(OH)D level will either normalize or remain normal in those who were previously vitamin D deficient or sufficient, respectively. All had subnormal bone mineral content before transplant. On long‐term follow‐up (>4 mo) of seven patients, bone mineral content normalized in all between 6.5 and 19 mo after transplant, with a mean of 11.2 + 4.5 mo. In six patients with normal serum 25(OH)D levels before orthotopic liver transplantation, the serum 25(OH)D levels had declined markedly 1 to 2 mo after transplant, followed by return to normal by 3 to 6 mo. Low serum 25(OH)D levels (<15 ng/ml) in three patients before orthotopic liver transplantation normalized after transplant. Although there was no correlation between bone mineral content and serum 25(OH)D level before transplant, sustained normal serum 25(OH)D and 1,25(OH)2D levels preceded or accompanied normalization of bone mineral content in the seven patients available for long‐term follow‐up. We conclude that (a) in infants and children younger than 2 yr with chronic cholestasis, bone mineral content normalizes approximately 11 mo after orthotopic liver transplantation. This normalization is preceded by a sustained period of normal serum 25(OH)D levels. (b) Normal baseline serum 25(OH)D levels decrease 1 to 2 mo after orthotopic liver transplantation, with subsequent normalization, whereas initially low serum 25(OH)D levels gradually normalize within 2 to 4 mo. We speculate that maintenance of normal serum 25(OH)D levels with oral vitamin D supplementation may enhance recovery of bone disease after orthotopic liver transplantation. (HEPATOLOGY 1994;20:598–603).

[1]  I. Björkhem,et al.  Selective inhibition of mitochondrial 27-hydroxylation of bile acid intermediates and 25-hydroxylation of vitamin D3 by cyclosporin A. , 1993, The Biochemical journal.

[2]  M. Slootweg,et al.  Growth Hormone and Bone , 1993, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[3]  B. Specker,et al.  Bone mineral content in infants and children with chronic cholestatic liver disease. , 1993, Pediatrics.

[4]  L. Carlsson,et al.  Growth hormone insensitivity associated with elevated circulating growth hormone-binding protein in children with Alagille syndrome and short stature. , 1993, The Journal of clinical endocrinology and metabolism.

[5]  B. Kommerell,et al.  Bone disease after liver transplantation. , 1992, Transplantation proceedings.

[6]  B. Hollis,et al.  d-α-Tocopheryl Polyethylene Glycol-1000 Succinate Enhances the Absorption of Vitamin D in Chronic Cholestatic Liver Disease of Infancy and Childhood , 1992, Pediatric Research.

[7]  J. Adams,et al.  Cyclosporin-A increases synthesis of 1,25-dihydroxyvitamin D3 in the rat and mouse. , 1991, Endocrinology.

[8]  E. Dickson,et al.  Bone disease in liver transplant recipients: incidence, timing, and risk factors. , 1991, Transplantation proceedings.

[9]  S. Epstein,et al.  Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. , 1988, Endocrinology.

[10]  H. Tanaka,et al.  Vitamin D metabolism in biliary atresia: intestinal absorptions of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3. , 1988, Journal of pediatric gastroenterology and nutrition.

[11]  R. Downs,et al.  Effect of short‐term glucocorticoids on serum osteocalcin in healthy young men , 1988, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  B. Specker,et al.  Bone mineral content in children 1 to 6 years of age. Detectable sex differences after 4 years of age. , 1987, American journal of diseases of children.

[13]  P. Stern,et al.  Cyclosporine a inhibits calcemic hormone‐induced bone resorption in vitro , 1986, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  R. Lorentzon,et al.  Intestinal absorption and 25-hydroxylation of vitamin D in patients with primary biliary cirrhosis. , 1982, Scandinavian journal of gastroenterology.

[15]  R. Francis,et al.  The effects of sex steroid and corticosteroid hormones on bone. , 1981, Journal of steroid biochemistry.

[16]  I. Rosenberg,et al.  7 Gastrointestinal-hepatic disorders and osteomalacia , 1980 .

[17]  I. Rosenberg,et al.  Bone disease in primary biliary cirrhosis: reversal of osteomalacia with oral 25-hydroxyvitamin D. , 1980, Gastroenterology.

[18]  B. Reilly,et al.  Pathogenesis of rickets in chronic hepatobiliary disease in children. , 1979, The Journal of pediatrics.

[19]  Y. Seino,et al.  THE PLASMA LEVELS OF 25‐HYDROXYVITAMIN D IN PATIENTS WITH VARIOUS LIVER DISEASES AND THE RESPONSE OF 25‐HYDROXYVITAMIN D TO VITAMIN D TREATMENT , 1978, Acta paediatrica Scandinavica.

[20]  J. Glasgow,et al.  THE OSTEODYSTROPHY OF PROLONGED OBSTRUCTIVE LIVER DISEASE IN CHILDHOOD , 1976, Acta paediatrica Scandinavica.

[21]  H. Rasmussen,et al.  The effect of Prednisolone upon the metabolism and action of 25-hydroxy-and 1,25-dihydroxyvitamin D3. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. Kobayashi,et al.  Bone disease in infants and children with hepatobiliary disease , 1974, Archives of disease in childhood.

[23]  L. Avioli,et al.  Effects of prednisone on vitamin D metabolism in man. , 1968, The Journal of clinical endocrinology and metabolism.

[24]  J. Cameron,et al.  Accuracy of Bone Mineral Measurement , 1964, Science.

[25]  B. Hollis,et al.  Solid phase extraction system for vitamin D and its major metabolites in human plasma. , 1985, Journal of chromatography.

[26]  L. Miravet,et al.  The Effect of Prednisolone ® upon the Metabolism and Action of 25-Hydroxy-and 1 , 25-Dihydroxyvitamin D 3 ( vitamin D / intestinal calcium absorption / adrenal steroids ) , 2022 .